203
Views
3
CrossRef citations to date
0
Altmetric
Review

Islamic fasting: cardiovascular disease perspective

, , , , ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 795-805 | Received 27 Jul 2022, Accepted 17 Oct 2022, Published online: 24 Oct 2022

References

  • Chamsi-Pasha M, Chamsi-Pasha H. The cardiac patient in Ramadan. Avicenna J Med. 2016;6(2):33–38.
  • Budhwani H, Borgstede S, Palomares AL, et al., Behaviors and risks for cardiovascular disease among Muslim women in the United States. Health Equity. 2018;2(1):264–271.
  • Di Francesco A, Di Germanio C, Bernier M, et al. A time to fast. Science. 2018;362(6416):770–775.
  • Ghouri N, Gatrad R, Sattar N, et al. Summer-winter switching of the Ramadan fasts in people with diabetes living in temperate regions. Diabet Med. 2012;29(6):696–697.
  • Trepanowski JF, Bloomer RJ. The impact of religious fasting on human health. Nutr J. 2010;9(1):57.
  • Azzoug S, Mahgoun S, Chentli F. Diabetes mellitus and Ramadan in elderly patients. J Pak Med Assoc. 2015;65(5 Suppl 1):S33–6.
  • Abolaban H, Al-Moujahed A. Muslim patients in Ramadan: a review for primary care physicians. Avicenna J Med. 2017;7(3):81–87.
  • Babineaux SM, Toaima D, Boye KS, et al. Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med. 2015;32(6):819–828.
  • Bragazzi NL. Ramadan fasting and chronic kidney disease: a systematic review. J Res Med Sci. 2014;19(7):665–676.
  • Bener A, Yousafzai MT. Effect of Ramadan fasting on diabetes mellitus: a population-based study in Qatar. J Egypt Public Health Assoc. 2014;89(2):47–52.
  • Mahmood A, Abbasi HN, Ghouri N, et al. Managing epilepsy in Ramadan: guidance for healthcare providers and patients. Epilepsy Behav. 2020;111:107117.
  • Nicholson LB. The immune system. Essays Biochem. 2016;60(3):275–301.
  • Delves PJ, Roitt IM, Mackay IR. The immune system: first of two parts. N Engl J Med. 2000;343(1):37–49.
  • Faris MAE, Salem ML, Jahrami HA, et al. Ramadan intermittent fasting and immunity: an important topic in the era of COVID-19. Ann Thorac Med. 2020;15(3):125–133.
  • Mendelsohn AR, Larrick JW. Prolonged fasting/refeeding promotes hematopoietic stem cell regeneration and rejuvenation. Rejuvenation Res. 2014;17(4):385–389.
  • Mushtaq R, Akram A, Mushtaq R, et al., The role of inflammatory markers following Ramadan Fasting. Pak J Med Sci. 2019;35(1):77–81.
  • Shariatpanahi MV, Shariatpanahi ZV, Shahbazi S, et al. Effect of fasting with two meals on BMI and inflammatory markers of metabolic syndrome. Pak J Biol Sci. 2012;15(5):255–258.
  • Latifynia A, Vojgani M, Gharagozlou MJ, et al. Effect of Ramadan on neutrophil’s respiratory burst (innate immunity) and circulating immune complex. J Ayub Med Coll Abbottabad. 2008;20(3):128–131.
  • Clifton KK, Ma CX, Fontana L, et al. Intermittent fasting in the prevention and treatment of cancer. CA Cancer J Clin. 2021;71(6):527–546.
  • Faris MA, Kacimi S, Al-Kurd RA, et al. Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutr Res. 2012;32(12):947–955.
  • Develioglu ON, Kucur M, Ipek HD, et al. Effects of Ramadan fasting on serum immunoglobulin G and M, and salivary immunoglobulin A concentrations. J Int Med Res. 2013;41(2):463–472.
  • Goharifar H, Faezi ST, Paragomi P, et al. The effect of Ramadan fasting on quiescent systemic lupus erythematosus (SLE) patients’ disease activity, health quality of life and lipid profile: a pilot study. Rheumatol Int. 2015;35(8):1409–1414.
  • Hassan A, Merghany N, Ouchkat F, et al. Impact of Ramadan fasting on disease activity in patients with multiple sclerosis: a multicenter study. Nutr Neurosci. 2021;28:1–10.
  • Saadatnia M, Etemadifar M, Fatehi F, et al. Short-term effects of prolonged fasting on multiple sclerosis. Eur Neurol. 2009;61(4):230–232.
  • Tavakkoli H, Haghdani S, Emami MH, et al. Ramadan fasting and inflammatory bowel disease. Indian J Gastroenterol. 2008;27(6):239–241.
  • Moghadam MT, Taati B, Paydar Ardakani SM, et al. Ramadan fasting during the COVID-19 pandemic; observance of health, nutrition and exercise criteria for improving the immune system. Front Nutr. 2021;7:570235.
  • Abaïdia AE, Daab W, Bouzid MA. Effects of Ramadan fasting on physical performance: a systematic review with meta-analysis. Sports Med. 2020;50(5):1009–1026.
  • Chamsi-Pasha H, Ahmed WH. The effect of fasting in Ramadan on patients with heart disease. Saudi Med J. 2004;25(1):47–51.
  • Al Suwaidi J, Zubaid M, Al-Mahmeed WA, et al. Impact of fasting in Ramadan in patients with cardiac disease. Saudi Med J. 2005;26(10):1579–1583.
  • Khafaji HA, Bener A, Osman M, et al. The impact of diurnal fasting during Ramadan on the lipid profile, hs-CRP, and serum leptin in stable cardiac patients. Vasc Health Risk Manag. 2012;8:7–14.
  • Raffee LA, Alawneh KZ, Al Suleiman MK, et al. An observational study of the occurrence of acute coronary syndrome (ACS) among Jordanian patients: identifying the influence of Ramadan Fasting. Ann Med Surg (Lond). 2020;59:171–175.
  • Salam AM, AlBinali HA, Salim I, et al. Impact of religious fasting on the burden of atrial fibrillation: a population-based study. Int J Cardiol. 2013;168(3):3042–3043.
  • Al Suwaidi J, Bener A, Hajar HA, et al. Does hospitalization for congestive heart failure occur more frequently in Ramadan: a population-based study (1991-2001). Int J Cardiol. 2004;96(2):217–221.
  • Temizhan A, Dönderici O, Ouz D, et al. Is there any effect of Ramadan fasting on acute coronary heart disease events? Int J Cardiol. 1999;70(2):149–153.
  • Al Suwaidi J, Bener A, Suliman A, et al. A population based study of Ramadan fasting and acute coronary syndromes. Heart. 2004;90(6):695–696.
  • Chamsi-Pasha H, Aljabri KS. The diabetic patient in Ramadan. Avicenna J Med. 2014;4(2):29–33.
  • Alper AT, Akboğa MK, Özcan KS, et al. Recommendations for Ramadan fasting to patients with cardiovascular diseases; Turkish society of cardiology consensus report. Anatol J Cardiol. 2021;25(5):284–293.
  • Salim I, Al Suwaidi J, Ghadban W, et al. Impact of religious Ramadan fasting on cardiovascular disease: a systematic review of the literature. Curr Med Res Opin. 2013;29(4):343–354.
  • Akhtar AM, Ghouri N, Chahal CAA, et al. Ramadan fasting: recommendations for patients with cardiovascular disease. Heart. 2022;108(4):258–265.
  • Malik S, Hamer R, Shabir S, et al. Effects of fasting on solid organ transplant recipients during Ramadan - a practical guide for healthcare professionals. Clin Med (Lond). 2021;21(5):e492–e498.
  • Billingsley HE, Canada JM, Dixon DL, et al. Midpoint of energy intake, non-fasting time and cardiorespiratory fitness in heart failure with preserved ejection fraction and obesity. Int J Cardiol. 2022;355:23–27.
  • Habbal R, Azzouzi L, Adnan K, et al. Variations tensionnelles au cours du mois de Ramadan [Variations of blood pressure during the month of Ramadan]. Arch Mal Coeur Vaiss. 1998;91(8):995–998.
  • Perk G, Ghanem J, Aamar S, et al. The effect of the fast of Ramadan on ambulatory blood pressure in treated hypertensives. J Hum Hypertens. 2001;15(10):723–725.
  • Erdem Y, Özkan G, Ulusoy Ş, et al. The effect of intermittent fasting on blood pressure variability in patients with newly diagnosed hypertension or prehypertension. J Am Soc Hypertens. 2018;12(1):42–49.
  • Beleslin B, Cirić J, Zarković M, et al. The effects of three-week fasting diet on blood pressure, lipid profile and glucoregulation in extremely obese patients. Srp Arh Celok Lek. 2007;135(7–8):440–446.
  • Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiol. 2017;2(7):775–781.
  • Aune D, Sen A, ó’Hartaigh B, et al. Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis. 2017;27(6):504–517.
  • Biesinger S, Michaels HA, Quadros AS, et al. A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects. Eur J Clin Nutr. 2016;70(1):10–16.
  • Mattson MP, Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem. 2005;16(3):129–137.
  • Wan R, Camandola S, Mattson MP. Intermittent food deprivation improves cardiovascular and neuroendocrine responses to stress in rats. J Nutr. 2003;133(6):1921–1929.
  • Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond). 2011 May;35(5):714–727.
  • Mager DE, Wan R, Brown M, et al. Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. FASEB J. 2006;20(6):631–637.
  • Hammoud S, Saad I, Karam R, et al. Impact of ramadan intermittent fasting on the heart rate variability and cardiovascular parameters of patients with controlled hypertension. J Nutr Metab. 2021;2021:6610455.
  • Sobko T, Marcus C, Govoni M, et al. Dietary nitrate in Japanese traditional foods lowers diastolic blood pressure in healthy volunteers. Nitric Oxide. 2010;22(2):136–140.
  • Mori TA, Bao DQ, Burke V, et al. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension. 1999;34(2):253–260.
  • Nicoll R, Henein MY. Caloric restriction and its effect on blood pressure, heart rate variability and arterial stiffness and dilatation: a review of the evidence. Int J Mol Sci. 2018;19(3):751.
  • Yousefi B, Faghfoori Z, Samadi N, et al. The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases. Eur J Clin Nutr. 2014;68(7):835–839.
  • Esmaeilzadeh F, De Borne P V. Does intermittent fasting improve microvascular endothelial function in healthy middle-aged subjects? Biol Med. 2016;8(6):1.
  • Jahrami HA, Faris ME, Janahi A I, et al. Does four-week consecutive, Dawn-to-sunset intermittent fasting during Ramadan affect cardiometabolic risk factors in healthy adults? A systematic review, meta-analysis, and meta-regression. Nutr Metab Cardiovasc Dis. 2021;31(8):2273–2301.
  • Wilkinson MJ, Manoogian ENC, Zadourian A, et al. Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metab. 2020;31(1):92–104.e5.
  • Schroder JD, Falqueto H, Mânica A, et al. Effects of time-restricted feeding in weight loss, metabolic syndrome and cardiovascular risk in obese women. J Transl Med. 2021;19(1):3.
  • Jeong EM, Liu M, Sturdy M, et al. Metabolic stress, reactive oxygen species, and arrhythmia. J Mol Cell Cardiol. 2012;52(2):454–463.
  • Wang CC, Yeh SJ, Wen MS, et al. Worsening of vasovagal syncope after beta-blocker therapy. Chest. 1994;106(3):963–965.
  • Gumprecht J, Lip GYH. In older patients with AF, antiarrhythmic drugs were linked to fall-related injuries and syncope vs rate-lowering drugs. Ann Intern Med. 2019;171(12):JC71.
  • Kahraman S, Dogan A. Ventricular arrhythmia linked to long intermittent fasting. J Electrocardiol. 2020;58:125–127.
  • Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17–96.
  • McDonagh TA, Metra M, Adamo M, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726.
  • January CT, Wann LS, Calkins H, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2019;74(1):104–132.
  • Alwhaibi A, Alenazi M, Alwagh F, et al. Does Ramadan fasting disrupt international normalized ratio control in warfarin-treated medically stable patients? Int J Clin Pract. 2021;75(11):e14796.
  • Sridharan K, Al Banna R, Qader AM, et al. Does fasting during Ramadan influence the therapeutic effect of warfarin? J Clin Pharm Ther. 2021;46(1):86–92.
  • Arsenault BJ, Rana JS, Stroes ES, et al. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol. 2009;55(1):35–41.
  • Ghosh A, Bhagat M, Das M, et al. Prevalence of cardiovascular disease risk factors in people of Asian Indian origin: age and sex variation. J Cardiovasc Dis Res. 2010;1(2):81–85.
  • Santos HO, Macedo RCO. Impact of intermittent fasting on the lipid profile: assessment associated with diet and weight loss. Clin Nutr ESPEN. 2018;24:14–21.
  • Fernando HA, Zibellini J, Harris RA, et al. Effect of ramadan fasting on weight and body composition in healthy non-athlete adults: a systematic review and meta-analysis. Nutrients. 2019;11(2):478.
  • Abdullah SM, Defina LF, Leonard D, et al. Long-Term association of low-density lipoprotein cholesterol with cardiovascular mortality in individuals at low 10-year risk of atherosclerotic cardiovascular disease. Circulation. 2018;138(21):2315–2325.
  • Andersson C, Lyass A, Vasan RS, et al. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study. Am Heart J. 2014;168(6):878–83.e1.
  • Nachvak SM, Pasdar Y, Pirsaheb S, et al. Effects of Ramadan on food intake, glucose homeostasis, lipid profiles and body composition. Eur J Clin Nutr. 2019;73(4):594–600.
  • Rahbar AR, Safavi E, Rooholamini M, et al. Effects of intermittent fasting during Ramadan on insulin-like growth factor-1, interleukin 2, and lipid profile in healthy muslims. Int J Prev Med. 2019;10(1):7.
  • Urooj A, Pai Kotebagilu N, Shivanna LM, et al. Effect of Ramadan fasting on body composition, biochemical profile, and antioxidant status in a sample of healthy individuals. Int J Endocrinol Metab. 2020;18(4):e107641.
  • Lamri-Senhadji MY, El Kebir B, Belleville J, et al. Assessment of dietary consumption and time-course of changes in serum lipids and lipoproteins before, during and after Ramadan in young Algerian adults. Singapore Med J. 2009;50(3):288–294.
  • Ongsara S, Boonpol S, Prompalad N, et al. The effect of Ramadan fasting on biochemical parameters in healthy Thai subjects. J Clin Diagn Res. 2017;11(9):BC14–BC18.
  • Mahboob S, Sattarivand R, Nouri M, et al. Effect of Ramadan fasting on serum lipid profiles in normal and hyperlipidemic subjects. Saudi Med J. 1999;20(12):947–950.
  • Rahman M, Rashid M, Basher S, et al. Improved serum HDL cholesterol profile among Bangladeshi male students during Ramadan fasting. East Mediterr Health J. 2004;10(1–2):131–137.
  • Akaberi A, Golshan A, Moojdekanloo M, et al. Does fasting in Ramadan ameliorate Lipid profile? A prospective observational study. Pak J Med Sci. 2014;30(4):708–711.
  • Malik J, Shabeer H, Ishaq U, et al. Modern lipid management: a literature review. Cureus. 2020;12(7):e9375.
  • Malinowski B, Zalewska K, Węsierska A, et al. Intermittent fasting in cardiovascular disorders-an overview. Nutrients. 2019;11(3):673.
  • Gabel K, Cienfuegos S, Kalam F, et al. Time-restricted eating to improve cardiovascular health. Curr Atheroscler Rep. 2021;23(5):22.
  • Kul S, Savaş E, Öztürk ZA, et al. Does Ramadan fasting alter body weight and blood lipids and fasting blood glucose in a healthy population? A meta-analysis. J Relig Health. 2014;53(3):929–942.
  • Mirmiran P, Bahadoran Z, Gaeini Z, et al. Effects of Ramadan intermittent fasting on lipid and lipoprotein parameters: an updated meta-analysis. Nutr Metab Cardiovasc Dis. 2019;29(9):906–915.
  • Faris MA, Jahrami H, BaHammam A, et al. A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on glucometabolic markers in healthy subjects. Diabetes Res Clin Pract. 2020;165:108226.
  • Saleh SA, El-Kemery TA, Farrag KA, et al. Ramadan fasting: relation to atherogenic risk among obese Muslims. J Egypt Public Health Assoc. 2004;79(5–6):461–483.
  • Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364–373.
  • Aybak M, Türkoğlu A, Sermet A, et al. Effect of Ramadan fasting on platelet aggregation in healthy male subjects. Eur J Appl Physiol Occup Physiol. 1996;73(6):552–556.
  • Gocer H, Gunday M, Abusharekh M, et al. To show the effect of intermittent fasting during ramadan on endothelial dysfunction via TIMI frame count. Niger J Clin Pract. 2021;24(6):943–947.
  • Osman F, Haldar S, Henry CJ. Effects of time-restricted feeding during ramadan on dietary intake, body composition and metabolic outcomes. Nutrients. 2020;12(8):2478.
  • Ali Z, Abizari AR. Ramadan fasting alters food patterns, dietary diversity and body weight among Ghanaian adolescents. Nutr J. 2018;17(1):75.
  • Rabea EM, Abbas KS, Awad DM, et al. Does ramadan fasting affect the therapeutic and clinical outcomes of warfarin? A systematic review and meta-analysis. Eur J Clin Pharmacol. 2022;78(5):755–763.
  • Hoffmann AP, Honigberg MC. Glycated hemoglobin as an integrator of cardiovascular risk in individuals without diabetes: lessons from recent epidemiologic studies. Curr Atheroscler Rep. 2022;24(6):435–442.
  • Hajek P, Myers K, Dhanji AR, et al. Weight change during and after Ramadan fasting. J Public Health (Oxf). 2012;34(3):377–381.
  • Pallayova M, Zaghloul HB, Arora T, et al. Investigating physiological glucose excursions before, during, and after Ramadan in adults without diabetes mellitus. Physiol Behav. 2017;179:110–115.
  • Belkacemi L, Selselet-Attou G, Hupkens E, et al. Intermittent fasting modulation of the diabetic syndrome in streptozotocin-injected rats. Int J Endocrinol. 2012;2012:962012.
  • Chaix A, Zarrinpar A, Miu P, et al. Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab. 2014;20(6):991–1005.
  • Faris MAE, Madkour MI, Obaideen AK, et al. Effect of Ramadan diurnal fasting on visceral adiposity and serum adipokines in overweight and obese individuals. Diabetes Res Clin Pract. 2019;153:166–175.
  • Neumann UH, Denroche HC, Mojibian M, et al. Insulin knockout mice have extended survival but volatile blood glucose levels on leptin therapy. Endocrinology. 2016;157(3):1007–1012.
  • Yanai H, Yoshida H. Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives. Int J Mol Sci. 2019;20(5):1190.
  • Liu M, Li XC, Lu L, et al. Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci. 2014;18(19):2918–2926.
  • Karohl C, Raggi P. Approach to cardiovascular disease prevention in patients with chronic kidney disease. Curr Treat Options Cardiovasc Med. 2012;14(4):391–413.
  • Alsughayer LY, Altamimi LA, Tarakji AR. Ramadan fasting among advanced chronic kidney disease patients. Nephrologists’ perspectives in Saudi Arabia. Saudi Med J. 2020;41(10):1070–1075.
  • Currie CJ, Berni ER, Berni TR, et al. Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status. PLoS One. 2019;14(8):e0221044.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.